Displaying items by tag: division of clinical immunology and rheumatology

Description of this mechanism offers a promising therapeutic target to limit lung injury and death. Lower respiratory tract infections, including bacterial pneumonia, are the fourth-leading cause of death worldwide, with 120 million to 156 million cases and 1.4 million deaths a year.
These effector memory B cells appear poised for a rapid serum antibody response upon secondary challenge one year later, and evidence shows that the cells in this subset differ from all previously described memory B cell subsets.
UAB rheumatologists will begin seeing patients at the UAB Hoover Primary Care clinic in July 2022.
As part of a study funded by Pfizer, Inc., UAB will partner with Whitfield Hospital in Demopolis and John Paul Jones Hospital in Camden to evaluate how thermography cameras can improve telemedicine visits for arthritis patients in rural Alabama.
Lupus, an autoimmune disease that can attack any part of the body, can be confounding because patients often respond differently to the same treatment, and they vary widely in the severity of their symptoms.
Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation.
Tagged under

This finding upends the long-held paradigm that priming during lung infections takes place only in the draining lymph nodes, and it will be key to developing more efficient vaccinations and therapies for respiratory challenges.

A recent grant to UAB researchers from a national organization will yield insight into telehealth and potentially increase patient access to rheumatic care.
A long time UAB rheumatologist has been named director of division in the UAB School of Medicine.   
Bridges will serve a two-year term as president of a specialty research foundation.
Page 1 of 5